Literature DB >> 18277734

Methadone induced torsade de pointes in a patient receiving antiretroviral therapy.

M Falconer1, D Molloy, J Ingerhaug, M Barry.   

Abstract

Adverse drug reactions account for approximately 5% of acute medical admissions. A 34-year-old male patient receiving antiretroviral therapy, methadone and flurazepam presented to the emergency room following collapse with associated loss of consciousness. Cardiac monitoring demonstrated marked Q-T prolongation followed by the cardiac arrhythmia, torsade de pointes. The patient made a full recovery following withdrawal of the antiretroviral therapy and a reduction in methadone dose. Methadone is a recognised cause of this potentially fatal cardiac arrhythmia which is more likely to occur when methadone metabolism is inhibited by drugs such as HIV tease inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18277734

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.

Authors:  Judith A Martin; Anthony Campbell; Thomas Killip; Margaret Kotz; Mori J Krantz; Mary Jeanne Kreek; Brian A McCarroll; Davendra Mehta; J Thomas Payte; Barry Stimmel; Trusandra Taylor; Mark C P Haigney; Bonnie B Wilford
Journal:  J Addict Dis       Date:  2011-10

2.  Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data.

Authors:  David Kao; Becki Bucher Bartelson; Vaishali Khatri; Richard Dart; Philip S Mehler; David Katz; Mori J Krantz
Journal:  Ann Intern Med       Date:  2013-05-21       Impact factor: 25.391

3.  Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; Thomas Clausen; Jayanthi N Koneru; Christopher Kogut; Ericka L Breden Crouse; Jules C Hancox; Antony Fernandez; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2013-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.